Question: Anti-amyloid immunotherapy dosing protocols and safety monitoring

ARIA-E incidence and MRI monitoring protocol in lecanemab trial

In audit

3/5 publication-ready

Findings metrics

—

total

—

verified

—

pending

—

rejected